Marketing-authorisation holder
Ajanta Pharma Ltd
10 medicines in 1 country, as authorisation holder and manufacturer.
Medicines
Every medicine in the registers under its name, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALMOTRIPTAN MALATE12.5mg base | 6.25mg base · Tablet | Almotriptan malate | United States | Marketed | 2015 |
| FAMOTIDINE40mg/5ml · For suspension | Famotidine | United States | Marketed | 2010 |
| GUANFACINE HYDROCHLORIDE1mg base | 2mg base · Tablet | Guanfacine | United States | Marketed | 1995 |
| OXCARBAZEPINE150mg | 300mg | 600mg · Tablet, extended release | Oxcarbazepine | United States | Marketed | 2018 |
| OXYBUTYNIN CHLORIDE10mg | 15 mg. | 15mg | 5mg · Tablet, extended release | Oxybutynin | United States | Marketed | 2006 |
| TERAZOSIN HYDROCHLORIDE10mg base | 1mg base | 2mg base | 5mg base · Capsule | Terazosin | United States | Marketed | 1998 |
| VALGANCICLOVIR HYDROCHLORIDE50mg/ml · For solution | Valganciclovir | United States | Marketed | 2016 |
| EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE10mg/1000mg | 12.5mg/1000mg | 25mg/1000mg | 5mg/1000mg · Tablet, extended release | Empagliflozin, Metformin | United States | tentative | 2026 |
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE1000mg | 50mg · Tablet | Metformin, Sitagliptin | United States | tentative | 2025 |
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE50mg/1000mg · Tablet | Sitagliptin, Metformin | United States | tentative | 2025 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 10 | 7 | 3 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- ajanta
- ajanta pharma limited
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 10
- Countries
- 1
- Roles
- Authorisation holder and manufacturer